The 20 Best Metastatic Pleural Tumor Doctors in Texas, US

Joe Chang is a Radiation Oncologist in Houston, Texas. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

Mara Antonoff is a General Surgeon in Sugar Land, Texas. Dr. Antonoff is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Lung Transplant.

Reza Mehran is a Thoracic Surgeon and a General Surgeon in Houston, Texas. Dr. Mehran is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Hepato-Pancreato-Biliary Surgery.

Dr. R. Taylor Ripley is a professor of Surgery and the Meyer-DeBakey Chair in Investigative Surgery. He serves as director of the Mesothelioma Treatment Center, Thoracic Surgical Research, and Clinical Trials for the Michael E. DeBakey Department of Surgery. He is a nationally recognized, board-certified Thoracic Surgeon and an expert in mesothelioma, lung cancer, esophageal cancer, chest wall tumors, and chest wall reconstruction. Additionally, Dr. Ripley focuses on Costal Margin Reconstruction for Slipping Rib Syndrome. Dr. Ripley specializes in Robotic Surgery to provide minimally-invasive approaches to thoracic diseases. He also practices all aspects of thoracic surgery including infectious lung disease, benign esophageal disease, and endoluminal procedures. Dr. Ripley received the ‘Top Doctors’ award by the Houstonia Magazine and the ‘Star Faculty Award for Excellence in Patient Care'.Dr. Ripley focuses on the treatment of patients with mesothelioma in which he is the principal investigator of the actively enrolling trial, ‘NEMO: Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural Mesothelioma.’ In this trial, patients will receive the maximum treatment to beat this disease. Patients will undergo treatment with immunotherapy with or without chemotherapy, then they will undergo surgery with an extended pleurectomy decortication or extrapleural pneumonectomy, then they will receive one year of immunotherapy.Dr. Ripley leads the Ripley Lab for Translational Thoracic Oncology Research (Thoracic Surgical Oncology Translational Laboratory (bcm.edu)) in which he focuses on methods to undermine tumors ability to resist treatment. His laboratory is funded with two National Cancer Institute, NIH, R01 grants, ‘Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma,’ and ‘Novel strategies to improve mesothelioma therapy’. Additionally, he received an award from the DeGregorio Family Foundation Grant for Gastric and Esophageal Malignancies, ‘Targeting Mitochondrial Resistance to Apoptosis after Neoadjuvant Therapy in Esophageal Adenocarcinoma’ to improve treatment for patients with esophageal cancer.Prior to his faculty appointment at BCM, Dr. Ripley was an Associate Professor of Surgery at National Cancer Institute, NIH. Prior to the NIH faculty appointment, Dr. Ripley trained extensively in the care of patients with mesothelioma and thoracic cancers under world-renowned surgeons during his fellowship at Memorial Sloan-Kettering Cancer Center in New York. He also completed a fellowship in Surgical Oncology at the NCI, NIH. Dr. Ripley did general surgery residency at the University of Colorado and received his Medical Doctorate from Vanderbilt University. Dr. Ripley is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Mesothelioma, Metastatic Pleural Tumor, Fibrosing Mediastinitis, Pleuropulmonary Blastoma, and Thymectomy.

James Caccitolo is a Surgical Oncologist and a Thoracic Surgeon in Tyler, Texas. Dr. Caccitolo is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Fibrosing Mediastinitis, Heart Bypass Surgery, and Advanced Bronchoscopy.

Shawn S. Groth, M.D. is a board-certified general thoracic surgeon in Houston who specializes in minimally invasive thoracic surgery. After finishing his cardiothoracic surgery residency under Dr. David J. Sugarbaker at the Brigham and Women’s Hospital, Harvard Medical School, Dr. Groth pursued an advanced fellowship in minimally invasive esophageal surgery at the University of Pittsburgh under the mentorship of Dr. James D. Luketich, a pioneer in minimally invasive foregut surgery. Dr. Groth seeks to bring that expertise to Baylor. As part of a team effort with other health care providers, Dr. Groth’s practice includes the multi-disciplinary management of benign and malignant disorders of the esophagus/foregut, lung, pleural space, mediastinum, chest wall, and diaphragm. As the Director of Esophageal Surgical Services at Baylor St. Luke’s Medical Center, Dr. Groth will co-direct a newly created swallow center, which will provide a multi-disciplinary approach to managing patients with gastroesophageal reflux disease and esophageal motility disorders. He provides minimally invasive approaches to managing benign (e.g., gastroesophageal reflux disease, paraesophageal hernias, achalasia, benign strictures, and esophageal diverticuli) and malignant foregut disorders (e.g., malignant strictures and esophageal and gastroesophageal junction cancers), as well as Barrett’s esophagus. Already a well-published investigator, Dr. Groth has presented his work at numerous national society meetings, including The American College of Surgeons, The American College of Chest Physicians, The American Society of Clinical Oncology, The Society of Thoracic Surgeons, and The American Association for Thoracic Surgery. Dr. Groth’s clinical research focuses on thoracic oncology outcomes research, health care disparities research, and clinical trials. He has explored several topics directed towards improving the guideline treatment of cancer patients. His basic science and translational research efforts are directed towards advancing personalized oncology. In light of the COVID-19 pandemic, the Baylor College of Medicine General Thoracic Surgery Clinic is offering telemedicine clinic visits. To schedule, please call the main line at 713-798-6376. Dr. Groth is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Mesothelioma, Achalasia, Metastatic Pleural Tumor, Endoscopy, and Gastrostomy.

Inderpal Sarkaria is a General Surgeon and a Thoracic Surgeon in Dallas, Texas. Dr. Sarkaria is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Esophageal Cancer, Hiatal Hernia, Lung Cancer, Thymectomy, and Endoscopy.

Dr. Schwartz is a thoracic surgeon with expertise in thoracic oncology, minimally invasive thoracic surgery, airway surgery, lung transplantation and extracorporeal membrane oxygenation. He completed a year of research focusing on thoracic oncology and endoscopic airway interventions. He has published many peer-reviewed publications and earned multiple clinical awards, including Chief Resident of the Year and the Charles McBurney Award. In addition, Dr. Schwartz serves in the following roles at Baylor University Medical Center: Chief, Department of Thoracic Surgery; Surgical Director, Lung Transplantation; Medical Director, Extracorporeal Membrane Oxygenation; and Surgical Director, Major Airway Disorders. He is married with four children and enjoys traveling, cooking, swimming and yoga. See Dr. Schwartz's Publications. Dr. Schwartz is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Lung Transplant, and Gastrostomy.

Shanda Blackmon is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Blackmon is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. Her top areas of expertise are Achalasia, Lung Cancer, Mesothelioma, Endoscopy, and Thymectomy. Dr. Blackmon is currently accepting new patients.

Yasir Elamin is an Oncologist in Houston, Texas. Dr. Elamin is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Metastatic Pleural Tumor.

Anne Tsao is an Oncologist in Houston, Texas. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. Her top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.

Vicente Valero is a Hematologist in Houston, Texas. Dr. Valero is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Metastatic Pleural Tumor.

Michael O'reilly is a Radiation Oncologist in Houston, Texas. Dr. O'reilly is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Metastatic Pleural Tumor, and Small Cell Lung Cancer (SCLC).

Saumil Gandhi is a Radiologist and a Radiation Oncologist in Houston, Texas. Dr. Gandhi is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Metastatic Pleural Tumor, Lung Cancer, and Mesothelioma.

Issam Alawin is an Oncologist in Houston, Texas. Dr. Alawin is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Angiosarcoma, Metastatic Pleural Tumor, Breast Cancer, and Paget Disease of the Breast. Dr. Alawin is currently accepting new patients.

Daniel Karp is a Hematologist in Houston, Texas. Dr. Karp is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Lung Cancer, Alveolar Soft Part Sarcoma, and Hodgkin Lymphoma.

Jordi Ahnert is an Oncologist in Houston, Texas. Dr. Ahnert is rated as a Distinguished provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Synovial Sarcoma, Pancreatic Cancer, and Metastatic Pleural Tumor.

Chad Strange is a Radiologist in Houston, Texas. Dr. Strange is rated as an Advanced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Mesothelioma, Metastatic Pleural Tumor, Pleurisy, and Pleural Effusion.

Binu Nair is a Hematologist and an Oncologist in Waxahachie, Texas. Dr. Nair is rated as an Experienced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Childhood Iron Deficiency Anemia.

Dr. Konduri attended medical school at the University College of Medical Sciences-India. He then completed a residency in Internal Medicine at Rush Presbyterian St Luke's - Westlake Residency Program, Melrose Park, Illinois, followed by a fellowship in Medical Oncology at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Konduri is certified in Internal Medicine and in Medical Oncology by the American Board of Internal Medicine. He specializes in medical oncology with a particular interest in lung and thoracic oncology. Dr. Konduri is rated as an Experienced provider by MediFind in the treatment of Metastatic Pleural Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.